Description

Conference RESERVED ONLY for the CIUSSS de l'Ouest-de-l'Île-de-Montréal.

Learning Objectives

PLACES ARE LIMITED TO 25 PARTICIPANTS.

By the end of these conferences, the participant will be able to:

A balanced look at triple therapy in COPD - A Case Study
1. Review the overall algorithm for pharmacological treatment for COPD patients according to national guidelines;
2. Use recent data around single inhaler triple therapy for COPD to compare to dual therapy or multiple inhaler triple therapy;
3. Discuss where current guidelines and literature stand with regards to this class of treatment in COPD;
4. Identify which patients could potentially benefit the most from single inhaler triple therapy;
5. Determine what considerations exist when the patient is on a triple therapy for COPD but remains uncontrolled - how to reassess and what remaining options are available.

The interaction between ADHD, mood disorders, and anxiety disorders
1. Describe the role of neurotransmitters in ADHD, mood disorders, and anxiety disorders
2. Differentiate between comorbid and dependent disorders
3. Discuss the etiology of substance use disorders: secondary/dependent to low dopaminergic syndrome as well as comorbid to ADHD, anxiety, and depression
4. Implement strategies to address comorbid conditions

Speakers

Moderator : Dr. Barbara Hogenbirk. Conferences given by Dr. Suzanne Levitz and Dr. John Sader.

Schedule

From 8:30 to 10:00, Conference
From 10:00 to 10:15, Break
From 10:15 to 11:45, Conference

Registration

It is important to register online in order to participate.
To cancel your registration, please contact Mrs. Aline Sabbagh at asabbagh@amom.net.

If you need any information, please contact Mrs Stephanie Kwong from AstraZeneca Canada at 514 235-3659 or at stephanie.kwong@astrazeneca.com or Mr. Rony Attar from Janssen at 514 585-3048 or at rattar@its.jnj.com.

The AMOM recommends that all participants follow the provincial health guidelines related to the COVID-19 pandemic. Participants acknowledge and accept the health risks that may be associated with in-person participation and understand that they are solely responsible for assessing their own health and taking appropriate safety measures for their situation.

Conference Venue

This conference will be held at the Brunswick Medical Centre, located at 955 Boul. Saint-Jean, Pointe-Claire, QC H9R 5K3.

Recognition of Educational Activities

L’Association des médecins omnipraticiens de Montréal, under the aegis of the FMOQ, recognizes 3.00 hours of professional development activity, of category 1, as required by the professional development regulations of the CMQ. The FMOQ number to retrieve your certificate is 83710.

Educational Subsidy

This activity has received an educational subsidy fromAstraZeneca Canada and Janssen.